Displaying 811 - 820 of 922 results
-
Oxycodone: How did we get here and how do we fix itThis article from Best Practice Journal (July 2014) 'How did we get here and how do we fix it' focuses on the increase in prescribing of oxycodone.
-
ARRC mini-collaborative evaluation report and case studiesThis toolkit is designed to help health care staff undertake quality improvement, specifically those working in aged residential care (ARC).
-
Consumer flyer: Ask your pharmacist for advice about your medicinesConsumer flyer: help with your medicines is available – ask your pharmacist for advice.
-
Gary's story: a consumer perspective on taking warfarinThis is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborativeThis poster 'Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative' was presented at the IHI's 28th annual national forum on quality improvement in health care.
-
Evaluation of the safe use of opioids national collaborativeThis report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.
-
ALERT 17: Alteplase or tenecteplase?An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Applying for specify brand advice statusUse this application form to apply for a new or changed specify brand advice listing.
-
Safe Medication Management newsletters - 2010Newsletters from the SMM programme for the year 2010
-
ALERT 4: Error-prone abbreviations, symbols and dose designations NOT TO USETo eliminate the risk associated with the use of error-prone abbreviations, symbols and dose designations when communicating any type of medicine-related information verbally, handwritten, pre-printed or electronically.